Business
DarioHealth Releases Study Demonstrating the Impact of Personalized Digital Interventions to Improve Self-Management of Diabetes
Study results to be presented at the 14th International Conference on Advanced Technologies and Treatments for Diabetes NEW YORK, June 4, 2021 /PRNewswire/ --

About this update from Dariohealth Corp.
[{"type":"text","content":"Study results to be presented at the 14th International Conference on Advanced Technologies and Treatments for Diabetes\n NEW YORK, June 4, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it will be presenting results of a new study at the 14th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2021; June 2-5, 2021). \nThe study, titled \"Impact of Digital Intervention Engine on Diabetes Self-Management,\" examined the effect of DarioHealth's highly personalized digital journeys on both clinical and engagement outcomes, applying user-specific digital intervention flows for behavioral change to increase user digital engagement.\nThis new research is a retrospective study of 246 DarioHealth users, and presents several meaningful outcomes achieved by the users:\nThe percentage of users who measured blood glucose was significantly higher in the test group of 127 Dario users receiving interventions driven by the digital intervention engine: 14% in first 30 days and 22% in 30-60 days; The average number of blood glucose measurements increased by 6% and 17% at first 30 days and 30-60 days, respectively; and Recency (average number of days between blood glucose measurements) was significantly improved by 30% in the test group.Most digital health solutions are personalized by applying generalized predictions across groups of \"like\" participants, not adapting to the truly unique needs of each participants. Dario's study found that personalizing the clinical interventions in response to unique individual circumstances, made possible by a powerful combination of AI, dynamically personalized user journeys, coaching, and behavior science, helps to durably improve self-monitoring and platform engagement among inconsistent users.\n\"The potential benefit of this research could be life-changing for so many people,\" said Dr. Yifat Hershcovitz, Ph.D., Scientific and Clinical Director at DarioHealth and one of the authors of the study. \"In the context of busy day-to-day life, simply remembering to perform blood glucose measurements at meaningful intervals may be a challenge. The results of this study confirm that DarioHealth's platform and hyper-personalized approach makes it much easier for people to remember to incorporate measuri...